glp-1 hfpef The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF) Frontiers | The potential of
Description
Among these NAEs, exenatide accounted for 10,175 cases (35.14%), liraglutide for 3,686 cases (12.73%), lixisenatide for 256 cases (0.88%), dulaglutide for 6,034 cases (20.84%), semaglutide for 5,935 cases (20.50%), and tirzepatide for 2,867 cases (9.90%)
The medication cannot be stopped, since most studies have shown weight regain when the patient stops using it
Brand-name Wegovy and Zepbound list between $900 and over $1,500 per month without insurance
GLP-1 medications & fertility Thinking about trying to conceive
Ignoring metabolic markers Weight is one data point
